These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22219502)

  • 1. Variation in HbA1c prescription for patients with diabetes in French general practice: an observational study prior to the implementation of a P4P programme.
    Chauvel N; Le Vaillant M; Pelletier-Fleury N
    Eur J Public Health; 2013 Feb; 23(1):61-6. PubMed ID: 22219502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic inertia and intensified treatment in diabetes mellitus prescription patterns: A nationwide population-based study in Taiwan.
    Huang LY; Yeh HL; Yang MC; Shau WY; Su S; Lai MS
    J Int Med Res; 2016 Dec; 44(6):1263-1271. PubMed ID: 28322095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation in Point-of-Care Testing of HbA1c in Diabetes Care in General Practice.
    Kristensen T; Waldorff FB; Nexøe J; Skovsgaard CV; Olsen KR
    Int J Environ Res Public Health; 2017 Nov; 14(11):. PubMed ID: 29120361
    [No Abstract]   [Full Text] [Related]  

  • 4. Association between gifts from pharmaceutical companies to French general practitioners and their drug prescribing patterns in 2016: retrospective study using the French Transparency in Healthcare and National Health Data System databases.
    Goupil B; Balusson F; Naudet F; Esvan M; Bastian B; Chapron A; Frouard P
    BMJ; 2019 Nov; 367():l6015. PubMed ID: 31690553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gaining insight into benzodiazepine prescribing in General Practice in France: a data-based study.
    Rosman S; Le Vaillant M; Pelletier-Fleury N
    BMC Fam Pract; 2011 May; 12():28. PubMed ID: 21569338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of anti-diabetic medication use in patients with type 2 diabetes mellitus in England and Wales.
    Datta-Nemdharry P; Thomson A; Beynon J; Donegan K
    Pharmacoepidemiol Drug Saf; 2017 Feb; 26(2):127-135. PubMed ID: 27642000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring Clinical Care Among Adults With Diabetes Mellitus: Alignment With Recommended Statin and Sulfonylureas Treatment.
    Sanchez-Ramirez DC; Singer A; Kosowan L; Polimeni C
    Can J Diabetes; 2019 Oct; 43(7):498-503. PubMed ID: 31307912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term effects of a pay-for-performance programme for diabetes in a primary care setting: an observational study.
    Ödesjö H; Anell A; Gudbjörnsdottir S; Thorn J; Björck S
    Scand J Prim Health Care; 2015; 33(4):291-7. PubMed ID: 26671067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membership in a diabetes-care network and adherence to clinical practice guidelines for treating type 2 diabetes among general practitioners: A four-year follow-up.
    Casanova L; Bocquier A; Cortaredona S; Nauleau S; Sauze L; Sciortino V; Villani P; Verger P
    Prim Care Diabetes; 2016 Oct; 10(5):342-51. PubMed ID: 27483997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using Consistently Low Performance to Identify Low-Quality Physician Groups.
    Nguyen CA; Gilstrap LG; Chernew ME; McWilliams JM; Landon BE; Landrum MB
    JAMA Netw Open; 2021 Jul; 4(7):e2117954. PubMed ID: 34319356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of diabetes care in Slovenia, Croatia, Serbia, Bulgaria and Romania : An observational, non-interventional, cross-sectional study.
    Cokolic M; Lalic NM; Micic D; Mirosevic G; Klobucar Majanovic S; Lefterov IN; Graur M
    Wien Klin Wochenschr; 2017 Mar; 129(5-6):192-200. PubMed ID: 27933508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The true impact of the French pay-for-performance program on physicians' benzodiazepines prescription behavior.
    Michel-Lepage A; Ventelou B
    Eur J Health Econ; 2016 Jul; 17(6):723-32. PubMed ID: 26304210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of pay-for-performance on diabetes care in a large network of community health centers.
    Coleman K; Reiter KL; Fulwiler D
    J Health Care Poor Underserved; 2007 Nov; 18(4):966-83. PubMed ID: 17982218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HbA1C, finding the right target in 2018.
    Vela D
    Diabetes Metab Syndr; 2018 Jul; 12(4):607-608. PubMed ID: 29622471
    [No Abstract]   [Full Text] [Related]  

  • 15. Prescription Patterns and the Cost of Antihyperglycemic Drugs in Patients With Type 2 Diabetes Mellitus in Germany.
    Jacob L; von Vultee C; Kostev K
    J Diabetes Sci Technol; 2017 Jan; 11(1):123-127. PubMed ID: 27402240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of clinical guideline adherence and pay-for-performance among patients with diabetes.
    Lai CL; Hou YH
    J Chin Med Assoc; 2013 Feb; 76(2):102-7. PubMed ID: 23351421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A model measuring therapeutic inertia and the associated factors among diabetes patients: A nationwide population-based study in Taiwan.
    Huang LY; Shau WY; Yeh HL; Chen TT; Hsieh JY; Su S; Lai MS
    J Clin Pharmacol; 2015 Jan; 55(1):17-24. PubMed ID: 25043457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium-glucose co-transporter-2 inhibitors, the latest residents on the block: Impact on glycaemic control at a general practice level in England.
    Heald AH; Fryer AA; Anderson SG; Livingston M; Lunt M; Davies M; Moreno GYC; Gadsby R; Young RJ; Stedman M
    Diabetes Obes Metab; 2018 Jul; 20(7):1659-1669. PubMed ID: 29516618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management and treatment goals in Polish patients with type 2 diabetes of short duration: results of the ARETAEUS2-Grupa study.
    Bała MM; Płaczkiewicz-Jankowska E; Leśniak W; Topór-Mądry R; Michałejko M; Jankowski M; Strzeszyński L; Sieradzki J; Czupryniak L;
    Pol Arch Med Wewn; 2013; 123(11):573-81. PubMed ID: 24241157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are general practitioners characteristics associated with the quality of type 2 diabetes care in general practice? Results from the Norwegian ROSA4 study from 2014.
    Tran AT; Bakke Å; Berg TJ; Gjelsvik B; Mdala I; Nøkleby K; Shakil Rai A; Cooper JG; Claudi T; Løvaas K; Thue G; Sandberg S; Jenum AK
    Scand J Prim Health Care; 2018 Jun; 36(2):170-179. PubMed ID: 29717939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.